EpicentRx
PrivateLast Round
Grant
Sep 17, 2024
Total Funding Raised
$47.31M
Company Overview
EpicentRx is a biotechnology company that develops a next-generation immunotherapy platform and small molecule therapies to treat cancer, inflammatory diseases, and other conditions with unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpicentRx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
EpicentRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Nov 29, 2022 | ||||
| Grant | Jul 12, 2022 | ||||
| Debt | Jan 6, 2021 | ||||
| Series D | Nov 14, 2019 |
EpicentRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FightMND | Grant |
| Shake it Up Australia Foundation | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Silicon Valley Bank | Debt |
EpicentRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpicentRx's valuation, stock price, and market status.